We used a bleomycin (BLM)-induced mouse PF model and a TGF-β1-induced EMT cell model to comprehensively explore the impact of this combination strategy on PF, with the hope of providing new treatment ideas and options for PF patients. This evidence concerns the gene TGFB1 and pemphigus foliaceus.